Who Are Suitable Patients for Omitting Breast Surgery as an Exceptional Responder in Selected Molecular Subtypes of Breast Cancer After Neoadjuvant Systemic Treatment?

Who Are Suitable Patients for Omitting Breast Surgery as an Exceptional Responder in Selected Molecular Subtypes of Breast Cancer After Neoadjuvant Systemic Treatment?

<i>Background and Objectives</i>: Among breast cancer molecular types, HER2 positive and triple negative (TN) subtypes have the highest likelihood of pathological complete response (pCR), which is a surrogate marker for reduced recurrence and improved patient survival after neoadjuvant s...

Full description

Saved in:
Bibliographic Details
Main Authors: Ebru Sen, Mehmet Ali Nazlı, Göktürk Maralcan, Bekir Sıtkı Said Ulusoy, Mahmut Kaan Demircioğlu, Tuce Söylemez Akkurt, Mehmet Sökücü, Gökmen Umut Erdem, Mustafa Yıldırım
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Medicina
Subjects:
neoadjuvant therapy
omission of surgery
postchemo-presurgical core biopsy
Online Access:https://www.mdpi.com/1648-9144/61/1/48
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items